Similar Articles
Anti-TNF Agents in Behçet's Disease Treatment
Semih Tatlıcan
A Takayasu's Arteritis Case with Unilateral Digital Clubbing
Mahmut ÇİVİLİBAL, Nilgün SELÇUK DURU, Gafur DOĞDU, Murat ELEVLİ, Semih AYTA
DOI: 10.5606/tjr.2011.025
The Reported Adverse Effects Related to Biological Agents Used for the Treatment of Rheumatic Diseases in Turkey
Erkan KILIÇ, Gamze KILIÇ, Özgür AKGÜL, Gürkan AKGÖL, Salih ÖZGÖÇMEN
DOI: 10.5606/tjr.2013.3052
A Rare Kind of Lymphoma in a Patient on Treatment With Two Different Biological Agents
Inesa ARSTIKYTE, Irena BUTRIMIENE, Agne PETRULIONIENE, Algirdas VENALIS
DOI: 10.5606/ArchRheumatol.2015.4383
Clinical Usefulness of Magnetic Resonance Imaging in Four Children With Scleroderma
Kazushi AGATA, Hisashi KAWASHIMA, Atsushi KUMADA, Yasuyo KASHIWAGI, Hiroko HARA
DOI: 10.5606/ArchRheumatol.2018.6498
Certolizumab Pegol Treatment in Three Patients With Takayasu Arteritis
Nuh ATAŞ, Özkan VARAN, Hakan BABAOĞLU, Hasan SATIŞ, Reyhan BİLİCİ SALMAN, Abdurrahman TUFAN
DOI: 10.5606/ArchRheumatol.2019.7177
Takayasu Arteritis: A Case Presenting With Neurological Symptoms and Proteinuria
Fatma AYDIN, Banu ACAR, Nermin UNCU, Özge BAŞARAN, Elçin ADALET YILDIZ, Alev GÜVEN, Nilgün ÇAKAR
DOI: 10.46497/ArchRheumatol.2020.7402
Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks
Murat KARKUCAK, Mehmet KOLA, Ahmet KALKIŞIM, Erhan ÇAPKIN, Ahmet AYAR, Adem TÜRK
DOI: 10.46497/ArchRheumatol.2021.7806
High prevalence of latent tuberculosis using the QuantiFERON-TB Gold Plus test in Takayasu arteritis
Ana Luisa Souza Pedreira, Rodrigo Pinheiro Leal Costa, Josenor Filipe Pitanga Silva, Mittermayer Barreto Santiago
DOI: 10.46497/ArchRheumatol.2022.9077